PYPD Completes FDA NDA Submission for D-PLEX 100, Targets Q1 2027 Approval, Phase 3 Shows 60% SSI Reduction
PolyPid Ltd. Ordinary Shares · Now $4.72
0.0% in 1h after detection
Post-detection moves
1h
0.0%
1d
—
3d
—
7d
—
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS